First Trust Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

First Trust Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-880,715	Closed	-$9.64M	–	87
2017 Q2	$9.64M	Buy	+880,715	New	+$9.66M	1.12%	22

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

First Trust Capital Management's ELOS Position: Q3 2017 in Review

First Trust Capital Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 880,715 shares — an estimated $9.64M sold.

First Trust Capital Management first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $9.64M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

First Trust Capital Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
First Trust Capital Management sold 880,715 Syneron Medical Ltd shares in Q3 2017, an estimated $9.64M.
First Trust Capital Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
First Trust Capital Management's Syneron Medical Ltd position peaked at $9.64M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on First Trust Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.